| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-11 17:46:33 UTC |
|---|
| Update Date | 2022-03-07 02:53:10 UTC |
|---|
| HMDB ID | HMDB0031926 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Trilobalicin |
|---|
| Description | Trilobalicin belongs to the class of organic compounds known as annonaceous acetogenins. These are waxy derivatives of fatty acids (usually C32 or C34), containing a terminal carboxylic acid combined with a 2-propanol unit at the C-2 position to form a methyl- substituted alpha,beta-unsaturated-gamma-lactone. One of their interesting structural features is a single, adjacent, or nonadjacent tetrahydrofuran (THF) or tetrahydropyran (THP) system with one or two flanking hydroxyl group(s) at the center of a long hydrocarbon chain. Based on a literature review a small amount of articles have been published on Trilobalicin. |
|---|
| Structure | CCCCCCCCCCC(O)C1CCC(O1)C(O)CCC(O)C1CCC(CCCCCC(O)CC2=CC(C)OC2=O)O1 InChI=1S/C35H62O8/c1-3-4-5-6-7-8-9-13-16-29(37)33-21-22-34(43-33)31(39)19-18-30(38)32-20-17-28(42-32)15-12-10-11-14-27(36)24-26-23-25(2)41-35(26)40/h23,25,27-34,36-39H,3-22,24H2,1-2H3 |
|---|
| Synonyms | | Value | Source |
|---|
| Trilobalicin | MeSH |
|
|---|
| Chemical Formula | C35H62O8 |
|---|
| Average Molecular Weight | 610.862 |
|---|
| Monoisotopic Molecular Weight | 610.44446896 |
|---|
| IUPAC Name | 3-[7-(5-{1,4-dihydroxy-4-[5-(1-hydroxyundecyl)oxolan-2-yl]butyl}oxolan-2-yl)-2-hydroxyheptyl]-5-methyl-2,5-dihydrofuran-2-one |
|---|
| Traditional Name | 3-[7-(5-{1,4-dihydroxy-4-[5-(1-hydroxyundecyl)oxolan-2-yl]butyl}oxolan-2-yl)-2-hydroxyheptyl]-5-methyl-5H-furan-2-one |
|---|
| CAS Registry Number | 189747-98-6 |
|---|
| SMILES | CCCCCCCCCCC(O)C1CCC(O1)C(O)CCC(O)C1CCC(CCCCCC(O)CC2=CC(C)OC2=O)O1 |
|---|
| InChI Identifier | InChI=1S/C35H62O8/c1-3-4-5-6-7-8-9-13-16-29(37)33-21-22-34(43-33)31(39)19-18-30(38)32-20-17-28(42-32)15-12-10-11-14-27(36)24-26-23-25(2)41-35(26)40/h23,25,27-34,36-39H,3-22,24H2,1-2H3 |
|---|
| InChI Key | FTBUPRVFMAYNFL-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as annonaceous acetogenins. These are waxy derivatives of fatty acids (usually C32 or C34), containing a terminal carboxylic acid combined with a 2-propanol unit at the C-2 position to form a methyl- substituted alpha,beta-unsaturated-gamma-lactone. One of their interesting structural features is a single, adjacent, or nonadjacent tetrahydrofuran (THF) or tetrahydropyran (THP) system with one or two flanking hydroxyl group(s) at the center of a long hydrocarbon chain. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Fatty alcohols |
|---|
| Direct Parent | Annonaceous acetogenins |
|---|
| Alternative Parents | |
|---|
| Substituents | - Annonaceae acetogenin skeleton
- 2-furanone
- Dihydrofuran
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Tetrahydrofuran
- Carboxylic acid ester
- Lactone
- Secondary alcohol
- Carboxylic acid derivative
- Dialkyl ether
- Oxacycle
- Ether
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Hydrocarbon derivative
- Organic oxygen compound
- Organic oxide
- Carbonyl group
- Alcohol
- Organooxygen compound
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 8.01 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 20.8957 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.79 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 78.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 4421.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 213.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 281.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 174.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 698.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1131.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 852.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 203.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 2076.5 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 798.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2402.0 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 616.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 564.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 219.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 302.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Trilobalicin,1TMS,isomer #1 | CCCCCCCCCCC(O[Si](C)(C)C)C1CCC(C(O)CCC(O)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O1 | 4763.4 | Semi standard non polar | 33892256 | | Trilobalicin,1TMS,isomer #2 | CCCCCCCCCCC(O)C1CCC(C(CCC(O)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O[Si](C)(C)C)O1 | 4777.6 | Semi standard non polar | 33892256 | | Trilobalicin,1TMS,isomer #3 | CCCCCCCCCCC(O)C1CCC(C(O)CCC(O[Si](C)(C)C)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O1 | 4778.1 | Semi standard non polar | 33892256 | | Trilobalicin,1TMS,isomer #4 | CCCCCCCCCCC(O)C1CCC(C(O)CCC(O)C2CCC(CCCCCC(CC3=CC(C)OC3=O)O[Si](C)(C)C)O2)O1 | 4756.2 | Semi standard non polar | 33892256 | | Trilobalicin,2TMS,isomer #1 | CCCCCCCCCCC(O[Si](C)(C)C)C1CCC(C(CCC(O)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O[Si](C)(C)C)O1 | 4723.0 | Semi standard non polar | 33892256 | | Trilobalicin,2TMS,isomer #2 | CCCCCCCCCCC(O[Si](C)(C)C)C1CCC(C(O)CCC(O[Si](C)(C)C)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O1 | 4723.2 | Semi standard non polar | 33892256 | | Trilobalicin,2TMS,isomer #3 | CCCCCCCCCCC(O[Si](C)(C)C)C1CCC(C(O)CCC(O)C2CCC(CCCCCC(CC3=CC(C)OC3=O)O[Si](C)(C)C)O2)O1 | 4690.9 | Semi standard non polar | 33892256 | | Trilobalicin,2TMS,isomer #4 | CCCCCCCCCCC(O)C1CCC(C(CCC(O[Si](C)(C)C)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O[Si](C)(C)C)O1 | 4728.9 | Semi standard non polar | 33892256 | | Trilobalicin,2TMS,isomer #5 | CCCCCCCCCCC(O)C1CCC(C(CCC(O)C2CCC(CCCCCC(CC3=CC(C)OC3=O)O[Si](C)(C)C)O2)O[Si](C)(C)C)O1 | 4708.8 | Semi standard non polar | 33892256 | | Trilobalicin,2TMS,isomer #6 | CCCCCCCCCCC(O)C1CCC(C(O)CCC(O[Si](C)(C)C)C2CCC(CCCCCC(CC3=CC(C)OC3=O)O[Si](C)(C)C)O2)O1 | 4707.3 | Semi standard non polar | 33892256 | | Trilobalicin,3TMS,isomer #1 | CCCCCCCCCCC(O[Si](C)(C)C)C1CCC(C(CCC(O[Si](C)(C)C)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O[Si](C)(C)C)O1 | 4658.0 | Semi standard non polar | 33892256 | | Trilobalicin,3TMS,isomer #2 | CCCCCCCCCCC(O[Si](C)(C)C)C1CCC(C(CCC(O)C2CCC(CCCCCC(CC3=CC(C)OC3=O)O[Si](C)(C)C)O2)O[Si](C)(C)C)O1 | 4633.5 | Semi standard non polar | 33892256 | | Trilobalicin,3TMS,isomer #3 | CCCCCCCCCCC(O[Si](C)(C)C)C1CCC(C(O)CCC(O[Si](C)(C)C)C2CCC(CCCCCC(CC3=CC(C)OC3=O)O[Si](C)(C)C)O2)O1 | 4620.4 | Semi standard non polar | 33892256 | | Trilobalicin,3TMS,isomer #4 | CCCCCCCCCCC(O)C1CCC(C(CCC(O[Si](C)(C)C)C2CCC(CCCCCC(CC3=CC(C)OC3=O)O[Si](C)(C)C)O2)O[Si](C)(C)C)O1 | 4629.8 | Semi standard non polar | 33892256 | | Trilobalicin,4TMS,isomer #1 | CCCCCCCCCCC(O[Si](C)(C)C)C1CCC(C(CCC(O[Si](C)(C)C)C2CCC(CCCCCC(CC3=CC(C)OC3=O)O[Si](C)(C)C)O2)O[Si](C)(C)C)O1 | 4543.7 | Semi standard non polar | 33892256 | | Trilobalicin,1TBDMS,isomer #1 | CCCCCCCCCCC(O[Si](C)(C)C(C)(C)C)C1CCC(C(O)CCC(O)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O1 | 4987.0 | Semi standard non polar | 33892256 | | Trilobalicin,1TBDMS,isomer #2 | CCCCCCCCCCC(O)C1CCC(C(CCC(O)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O[Si](C)(C)C(C)(C)C)O1 | 4998.7 | Semi standard non polar | 33892256 | | Trilobalicin,1TBDMS,isomer #3 | CCCCCCCCCCC(O)C1CCC(C(O)CCC(O[Si](C)(C)C(C)(C)C)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O1 | 4996.3 | Semi standard non polar | 33892256 | | Trilobalicin,1TBDMS,isomer #4 | CCCCCCCCCCC(O)C1CCC(C(O)CCC(O)C2CCC(CCCCCC(CC3=CC(C)OC3=O)O[Si](C)(C)C(C)(C)C)O2)O1 | 4993.5 | Semi standard non polar | 33892256 | | Trilobalicin,2TBDMS,isomer #1 | CCCCCCCCCCC(O[Si](C)(C)C(C)(C)C)C1CCC(C(CCC(O)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O[Si](C)(C)C(C)(C)C)O1 | 5159.9 | Semi standard non polar | 33892256 | | Trilobalicin,2TBDMS,isomer #2 | CCCCCCCCCCC(O[Si](C)(C)C(C)(C)C)C1CCC(C(O)CCC(O[Si](C)(C)C(C)(C)C)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O1 | 5155.3 | Semi standard non polar | 33892256 | | Trilobalicin,2TBDMS,isomer #3 | CCCCCCCCCCC(O[Si](C)(C)C(C)(C)C)C1CCC(C(O)CCC(O)C2CCC(CCCCCC(CC3=CC(C)OC3=O)O[Si](C)(C)C(C)(C)C)O2)O1 | 5150.6 | Semi standard non polar | 33892256 | | Trilobalicin,2TBDMS,isomer #4 | CCCCCCCCCCC(O)C1CCC(C(CCC(O[Si](C)(C)C(C)(C)C)C2CCC(CCCCCC(O)CC3=CC(C)OC3=O)O2)O[Si](C)(C)C(C)(C)C)O1 | 5159.9 | Semi standard non polar | 33892256 | | Trilobalicin,2TBDMS,isomer #5 | CCCCCCCCCCC(O)C1CCC(C(CCC(O)C2CCC(CCCCCC(CC3=CC(C)OC3=O)O[Si](C)(C)C(C)(C)C)O2)O[Si](C)(C)C(C)(C)C)O1 | 5163.8 | Semi standard non polar | 33892256 | | Trilobalicin,2TBDMS,isomer #6 | CCCCCCCCCCC(O)C1CCC(C(O)CCC(O[Si](C)(C)C(C)(C)C)C2CCC(CCCCCC(CC3=CC(C)OC3=O)O[Si](C)(C)C(C)(C)C)O2)O1 | 5159.5 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0007-0494540000-d49fcbe4eed288fc8b36 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (1 TMS) - 70eV, Positive | splash10-02g9-5097738000-1cbed89afacd6853aee6 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TMS_4_1) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trilobalicin GC-MS (TBDMS_2_5) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trilobalicin 10V, Positive-QTOF | splash10-01r6-0011193000-86112564b181fcddcf59 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trilobalicin 20V, Positive-QTOF | splash10-0006-2963560000-1a2c375702d64e2370c7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trilobalicin 40V, Positive-QTOF | splash10-0uml-5972320000-2fb4b7102c8e999909b2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trilobalicin 10V, Negative-QTOF | splash10-0a4i-1101079000-0f0d5a48414a6dd101a0 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trilobalicin 20V, Negative-QTOF | splash10-0005-9221151000-04ceff96ced89dc158b4 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trilobalicin 40V, Negative-QTOF | splash10-03xr-3192220000-71576a5882375dc83198 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trilobalicin 10V, Positive-QTOF | splash10-004l-1010292000-2d14942a8db7bbbdef18 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trilobalicin 20V, Positive-QTOF | splash10-004l-2001191000-8a53ddd5a84667ac3e4d | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trilobalicin 40V, Positive-QTOF | splash10-0006-9301200000-004674577a466a8d3485 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trilobalicin 10V, Negative-QTOF | splash10-0a4i-2000109000-e9954e404b796368780c | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trilobalicin 20V, Negative-QTOF | splash10-0aor-1637659000-9dbd4fdf8570d22f2247 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trilobalicin 40V, Negative-QTOF | splash10-00or-8749721000-42314013550981e45e97 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|